Trade OPKO Health, Inc. - OPK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0280 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.456 |
| Open | 1.456 |
| 1-Year Change | 54.78% |
| Day's Range | 1.456 - 1.476 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | 1.4560 | 0.0000 | 0.00% | 1.4560 | 1.4760 | 1.4460 |
| Jan 16, 2025 | 1.4560 | -0.0200 | -1.36% | 1.4760 | 1.4860 | 1.4560 |
| Jan 15, 2025 | 1.4660 | -0.0100 | -0.68% | 1.4760 | 1.4960 | 1.4560 |
| Jan 14, 2025 | 1.4660 | -0.0500 | -3.30% | 1.5160 | 1.5260 | 1.4360 |
| Jan 13, 2025 | 1.5160 | 0.0700 | 4.84% | 1.4460 | 1.5360 | 1.4460 |
| Jan 10, 2025 | 1.4660 | 0.0200 | 1.38% | 1.4460 | 1.4860 | 1.4160 |
| Jan 8, 2025 | 1.4760 | 0.0000 | 0.00% | 1.4760 | 1.4960 | 1.4460 |
| Jan 7, 2025 | 1.4960 | 0.0400 | 2.75% | 1.4560 | 1.5060 | 1.4560 |
| Jan 6, 2025 | 1.4460 | 0.0000 | 0.00% | 1.4460 | 1.4760 | 1.4460 |
| Jan 3, 2025 | 1.4660 | 0.0200 | 1.38% | 1.4460 | 1.4660 | 1.4260 |
| Jan 2, 2025 | 1.4360 | -0.0200 | -1.37% | 1.4560 | 1.5160 | 1.4360 |
| Dec 31, 2024 | 1.4660 | 0.0100 | 0.69% | 1.4560 | 1.4860 | 1.4460 |
| Dec 30, 2024 | 1.4560 | 0.0000 | 0.00% | 1.4560 | 1.4660 | 1.4260 |
| Dec 27, 2024 | 1.4760 | 0.0000 | 0.00% | 1.4760 | 1.5160 | 1.4460 |
| Dec 26, 2024 | 1.5060 | 0.0100 | 0.67% | 1.4960 | 1.5260 | 1.4660 |
| Dec 24, 2024 | 1.4960 | -0.0100 | -0.66% | 1.5060 | 1.5160 | 1.4860 |
| Dec 23, 2024 | 1.4960 | -0.0200 | -1.32% | 1.5160 | 1.5360 | 1.4960 |
| Dec 20, 2024 | 1.5360 | 0.0000 | 0.00% | 1.5360 | 1.5560 | 1.5260 |
| Dec 19, 2024 | 1.5660 | 0.0200 | 1.29% | 1.5460 | 1.5860 | 1.5360 |
| Dec 18, 2024 | 1.5560 | -0.0100 | -0.64% | 1.5660 | 1.6360 | 1.5460 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
OPKO Health, Inc. Company profile
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company''s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women''s health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company''s Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.| Industry: | Medical & Diagnostic Laboratories |
4400 Biscayne Blvd.
MIAMI
FLORIDA 33137
US
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com